Health AI Central
Share:
Peer-Reviewed Publication
Psychooncology2022;31(1):152-156.January 1, 2022Journal Article

Perceptions of BELONG as a supportive e-platform used by women with gynecologic cancers.

Saima Ahmed1,2, Walter H Gotlieb1,2,3,4, Guy Erez5, Carmen G Loiselle1,2,3,6
1Division of Experimental Medicine, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
2Segal Cancer Centre, Jewish General Hospital, Montreal, Canada.
3Department of Oncology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
4Department of Obstetrics and Gynecology, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
5Belong.Life Inc., New York, USA.
6Ingram School of Nursing, Faculty of Medicine and Health Sciences, McGill University, Montreal, Canada.
PubMed DOI

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free AccountSign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.